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Abstract
Background: Cisplatin is an effective anticancer drug that elicits many side effects mainly due to induction of oxidative and
nitrosative stresses during prolonged chemotherapy. The severity of these side effects consequently restricts its clinical use
under long term treatment. Riboflavin is an essential vitamin used in various metabolic redox reactions in the form of flavin
adenine dinucleotide and flavin mononucleotide. Besides, it has excellent photosensitizing property that can be used to
ameliorate these toxicities in mice under photodynamic therapy.
Methods and Findings: Riboflavin, cisplatin and their combinations were given to the separate groups of mice under
photoilluminated condition under specific treatment regime. Their kidney and liver were excised for comet assay and
histopathological studies. Furthermore, Fourier Transform Infrared Spectroscopy of riboflavin-cisplatin combination in vitro
was also conducted to investigate any possible interaction between the two compounds. Their comet assay and
histopathological examination revealed that riboflavin in combination with cisplatin was able to protect the tissues from
cisplatin induced toxicities and damages. Moreover, Fourier Transform Infrared Spectroscopy analysis of the combination
indicated a strong molecular interaction among their constituent groups that may be assigned for the protective effect of
the combination in the treated animals.
Conclusion: Inclusion of riboflavin diminishes cisplatin induced toxicities which may possibly make the cisplatin-riboflavin
combination, an effective treatment strategy under chemoradiotherapy in pronouncing its antineoplastic activity and
sensitivity towards the cancer cells as compared to cisplatin alone.
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Introduction
Cisplatin (CP) or cis- diamminedichloroplatinum (II), a plati-
num based antineoplastic agent, is one of the prominent members
of the most effective broad spectrum anticancer drugs used against
cervical, head and neck, prostrate, breast, lung, testicular and
ovarian cancers [1]. The anticancer activity of this drug is
attributed to its capability to form covalent bonds at N-7 position
of purine residues of DNA leading to formation of 1, 2 or 1, 3-
intrastrand crosslinks and a lesser extent of the interstrand
crosslinks. These adducts of CP-DNA derail the cellular replica-
tion and transcription machinery if these lesions anyhow evade
DNA repair system in the effected cells [2]. Many labs including
ours have demonstrated that CP generates free radicals leading to
oxidative and nitrosative stress which results into such deleterious
effects in vivo [3,4].
Riboflavin (RF) or vitamin B2 is an essential vitamin that is
required for normal cellular functions, growth and development in
all aerobic forms of life. It occurs in two major forms- flavin
adenine mononucleotide (FMN) and flavin adenine dinucleotide
(FAD) that participate in various metabolic redox reactions
including electron transport chain in mitochondria and also as a
prosthetic group of many enzymes like glutathione reductase and
succinate dehydrogenase. It can undergo photolysis and photo-
addition leading to generation of various free radicals having
potential to exert derogatory effects on the macromolecules in vitro
and in vivo [5,6,7]. Furthermore, being an excellent photosensitiz-
er, it is used in photodynamic therapy (PDT) and ribophotother-
apy (RPT) for treatment of various diseases including cancer [8,9].
Interestingly, deficiency of this vitamin has been ascribed to play a
prominent role in progression of various cancers as well as
increased vulnerability of the cells to cancer [10]. RF has been
manifested to enhance antitumor activity of many anticancer
drugs as well as in boosting the immune system to kill tumor cells
[11,12].
Despite being an effective antiproliferative agent, the clinical
usage of CP is limited by various side effects including
nephrotoxicity, hepatotoxicity, neurotoxicity and ototoxicity. They
force the patients either to limit its dose or discontinue its use
during long term CP based chemotherapy. Hence, amelioration or
decreasing the severity of CP elicited toxicity is one the major
clinical challenges in the cancer research arena for the last two
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[1,13,14,15]. In the recent past, our lab has demonstrated that
the photosensitizing property of RF can be used to alleviate the
toxicities induced by CP in situ and in vivo [4,16]. Our present work
is the first to study the blunting effect of cisplatin-riboflavin
combination on cisplatin induced toxicities in vivo at the molecular
level.
Materials and Methods
Materials
Cisplatin, riboflavin, normal melting agarose (NMA), ethidium
bromide (EtBr), Histopaque 1077, Hank’s balanced salt (HBSS),
RPMI 1640 and low melting point agarose (LMPA) were
purchased from Sigma- Aldrich Chemical Company, USA.
Ethylenediaminetetraacetic acid (EDTA), triton X-100, tris-
HCl, NaCl, Na2HPO4, NaH2PO4 and NaOH were bought from
Qualigens Fine chemical company, India. All other chemicals used
were purchased from Sisco Research Lab, Mumbai and HiMedia
Laboratories Private Limited, Mumbai.
Animal husbandry and treatment
Forty two adult Swiss albino male mice of 6 months’ age
weighing 48–50 g were purchased from the Central Animal House
of Jamia Hamdard University, New Delhi, India. . The animals
were housed in sufficiently large cages and treated under humane
and hygienic conditions with maintained 2562uC and 12 hours
day: night cycle according to ‘Departmental Ethical Committee
for Animal Experimentation’. They were acclimatized for 10 days
before the treatment on standard pellet mice diet (Ashirwad
Industries, Chandigarh, India) and clean drinking water ad libitum.
Animal experimentations were permitted by Ministry of
Environment and Forests, Government of India under registration
no 714/02/a/CPCSEA issued by Committee for the Purpose of
Control and Supervision of Experiments on Animals (CPCSEA)
dated 16th November, 2002. All experiments on animals were
approved by Departmental Ethical Committee (acad/D-833/
ILK/07-09-2007).
They were divided into 7 groups randomly taking 6 mice in
each group. They were named as- group I [control], group II
[treated with riboflavin at the dose of 2 mg/kg body weight],
group III [treated with cisplatin at the dose of 2 mg/kg body
weight]. The combination of CP and RF was named as group IV
[treated with the dose of 2 mg/kg body weight of CP with 1 mg/
kg body weight of RF (CP+RF1)] and Group V [treated with the
dose of 2 mg/kg body weight of CP with 2 mg/kg body weight of
RF (CP+RF2)] respectively. Group I was injected with saline only
in equal volume of the dose given to the treatment groups. All
these groups were exposed to full body irradiation under florescent
light [Philips, India] kept at ,10 cm distance at fluence rate of
38.6 W/m
2 for 12 hours daily during daytime. Parallel to these,
additional two combination groups without exposure of light - IV9
(CP+RF1) and V9 (CP+RF2) were also maintained. All the doses
were injected intraperitonially with 1 ml capacity syringe using
saline as vehicle solution for all the treatment. RF was injected
prior to CP by K hour in all the combination treated groups [IV,
IV9, V and V9]. The dorsal surface of all the mice was mildly
shaved for maximum possible absorption of light through the skin.
The mice were given a daily injection for 3 days followed by a gap
of a week; then again a daily dose for 3 days with a week gap and
finally 3 more daily injections were given. This treatment schedule
was applied to mimic the current cancer treatment strategy for the
patients. The treatment strategy, dose and the duration of
treatment were chosen to study the chronic effect of the treatment
at moderately toxic dose of the drug. Group I was taken as the
control for comparison with all other groups. All the mice were
healthy during the whole treatment. All the animals were
sacrificed on the same day by cervical dislocation method on the
next day to the final dose given.
Preparation of samples
After the sacrifice, their kidneys and livers were washed with ice-
cold saline buffer. Each of the samples was cut with sterilized blade
into two parts: one portion was kept in HBSS for comet assay
while the rest was stored in 10% formalin for their histopatho-
logical studies.
For comet assay, the organs were submerged in HBSS with a
pinch of EDTA and RPMI 1640 followed by their chopping into
small cubes of 2–3 nm thickness in separate Petri dishes. Their
solutionsweresievedbymuslinclothintofreshPetri dishestocollect
their cell suspension and were properly labeled. Cell viability test
was conducted for all the samples by trypan blue exclusion method.
Procedure of comet Assay
The assay was performed in alkaline condition in accordance
with protocol of Singh et al. with few modifications. Fully frosted
slides precoated with 1% NMA (as base layer) at 60uC were
prepared a day before sacrificing the animals. About 10,000 cells
isolated from each organ cell suspension were mixed with 100 ml
1% of LMPA to form the working cell suspension separately for
each organ. This suspension was pipetted over the base layer at
37uC followed by covering with cover slips immediately. After
solidification of second layer by keeping on ice packs, the cover
slips were removed and a third layer of 0.5% LMPA (100 ml) was
pipetted over followed by covering with cover slips and kept on ice
packs again. After that, the cover slips were removed and the slides
were immerged in cold lysing solution (2.5 M NaCl+100 mM
EDTA+10 mM tris-base+1% triton X-100) of pH 10 and were
kept as such for 3 hours. They were allowed to unwind in alkaline
electrophoretic running buffer (300 mM NaOH + 1 mM EDTA)
having pH 13 in electrophoretic tank for 30 minutes. Then,
electrophoresis was performed for 35 minutes at 4uC with constant
field strength of 0.74 volts/cm and current strength of 300 mA.
After gently washing with cold saline thrice, the slides were placed
in neutralizing buffer (0.4 M tris-base) of pH 7.5 followed by
washing with cold saline. The process of neutralization followed by
washing was repeated thrice. Their staining was done with 80 ml
ethidium bromide (20 mg/ml) for 5 minutes. Finally, the slides
were washed with chilled saline for three times and cover slips
were placed on. They were kept in humidified slide box in
refrigerator and were analyzed on the next day. The slides were
scored with CX41 fluorescent microscope (Olympus, Japan)
coupled with an image analysis system (Komet 5.5, Kinetic
imaging, Liverpool, U.K.) that was attached to integrated CC
camera COHU 4910 (equipped with 510–560 nm excitation and
590 nm barrier filters). The comets were scored at the magnifi-
cation of 1006and images of 50 cells (25 from each replicate slide)
for each sample were scored. Comet tail-length (migration of DNA
from its nucleus in mm) was chosen as the parameter to assess the
nuclear DNA damage for the present study.
Histopathological study of kidney and liver samples of
treated mice
For histopathology, the kidney and liver samples were kept in 10%
formalin for immersion fixation. 106563 mm sized tissue blocks of
both the organs were processed for paraffin embedding. Their
sections of 7 micrometer (mm) thickness were cut with rotary
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sections were observed under trinocular light microscope (Olympus
BX40, Japan) and their photomicrographs were snapped at
magnification of6400. After sectioning of the organs, five randomly
selected sections from each group of both organs were subjected to
counting of cells under light microscopy manually. The cells showing
normal shape and size with clear and well defined nucleus and intact
cytoplasm were considered as normal cells. The cells demonstrating
shrinkage or partial/complete disappearance of nucleus were
considered as apoptotic cells whereas cells showing fuzzy nucleus
and scanty cytoplasm were assumed as cells undergoing necrosis.
Fourier Transform Infrared Spectroscopy (FT-IR) of RF, CP
and their combinations
To get the insight picture of any possible interaction between the
two compounds, the aqueous solution of RF (50 mM), CP (50 mM)
and their combination were prepared freshly followed by their
incubation under fluorescent light for 1 hour parallel with their
controls without any light exposure. The samples were sandwiched
between two potassium bromide discs by hydraulic pressing and
their infrared spectra were recorded by Shimadzu-8300 FTIR
spectrophotometer (Tokyo, Japan). Their scanning range was set at
600–2000 cm
21 with resolution of 4 cm
21.
Statistical analysis
All the data has been expressed in mean 6 SEM (standard error
of mean). Comparisons among various groups were conducted by
one way –ANOVA with the help of software ‘Origin 6.1’ and
‘GraphPad Prism 5’. p #0.05 was chosen as statistically significant
for the treatment. The experiments were repeated thrice to check
the reproducibility of the results.
Results
CP- RF combination demonstrated better recovery from
CP induced nuclear DNA damage in kidney and liver
samples as assessed by comet assay
CP and RF treatment under photoillumination caused major
DNA damage in the kidney and liver samples as evidenced by
elongated tail length in group III and II with respect to the control
(group I). Group II showed increase in tail length in kidney and
liver cells by 115.8% and 103% [Figure 1(B) and 2(B)] while group
III demonstrated the increment in the tail length in kidney and
liver cells by 231.6% and 218.2% respectively [Figure 1(C) and
2(C)]. The combination groups under photoillumination showed
dose dependent recovery in CP induced DNA damage as group
IV and V demonstrated decrease in the tail length by 26.6% and
55.6% in the kidney cells [Figure 1(D) and 1(E)] while 28.6% and
59.5% in the liver cells respectively [Figure 2(D) and 2(E)] as
compared to group III. Among the combination groups without
light exposure, group V9 displayed 13.5% and 16.2% recovery in
tail-length in kidney and liver cells followed by group IV9 showing
the recovery by 6.4% and 7.6% in kidney and liver cells
respectively (Figures not shown) indicating the better recovery
under the effect of light (Table 1; Table S1).
Histopathological studies showed healing effect of
cisplatin induced tissue damage by riboflavin in the
combination treated group
The liver histomicrograph of group II [Figure 3(B)] was
appeared to be normal having the contour of hepatocytes intact
while sinusoids remained patent without any sign of congestion
except enlargement of the hepatocytes with respect to the control
[Figure 3(A)]. The liver section of CP treated group III showed
prominent alteration in the hepatic microstructure including
altered contour of hepatocytes, sparse presence of cell organelles,
shrunken nuclei, collapsed sinusoids and poorly maintained
hepatic cords [Figure 3(C)]. These cellular features indicate that
the cells were severely damaged and most of them were either
undergoing apoptotic or necrotic pathway. Group IV liver
histomicrograph revealed intact hepatic cords, hepatocyte contour
and patent sinusoids [Figure 3(D)] which was closely comparable
to the control group. These are suggestive of ameliorating effect of
riboflavin in CP-RF combination treated mice under photoillu-
minated condition [Figure 3(D)] while its counterpart; the
combination treated group without photoillumination didn’t show
any significant improvement in their tissue sections [Figures not
shown].
The kidney section from group II [Figure 4(B)] was found very
much comparable to the control group [Figure 4(A)] showing no
any evident change in its microanatomy of renal tubules and renal
corpuscles. Kidney histomicrograph of the CP treated group III
showed structural features of acute tubular necrosis characterized
by swelling which could be due to loss of apical portion or
separation tubular epithelium from its basement membrane at
various sites [Figure 4(C)]. The combination treated group IV
histomicrograph depicted renal tubules as normal comparable the
Figure 1. Showing the average comet picture of kidney from
different treated groups of mice. Average comet picture of kidney
samples of various treated mice groups divided as (A) Control as Group
I (B) Riboflavin treated as Group II (C) Cisplatin treated as Group III (D)
Combination I as Group IV (E) Combination II as Group V.
doi:10.1371/journal.pone.0036273.g001
Riboflavin Ameliorates Cisplatin-Toxicities
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36273control. However, the lumina of some of their tubules showed
renal casts possibly arising from the sloughing of tubular
epithelium. In addition, the lining of epithelial cells appeared flat
as compared to the control. Hence, the combination treated group
IV exhibited less cisplatin induced structural aberrations which is
indicative of the ameliorative effect of riboflavin in the group
[Figure 4(D)].
After qualitative histopathological examination of the tissue
sections, semiquantitative cell counting was performed on randomly
selected five tissue sections of both the kidney and liver from all the
groups. As kidney parenchyma consists of diverse type of cells; the
cells per renal tubule epithelium were taken as the parameter to
count the cells. It was observed that number of cells showing
necrotic features was highest in group III followed by group II while
the cells showing apoptotic features was more prominent in group
IV with decrease in number of cells undergoing necrosis as com-
pared to group III.
In liver, because of the uniformity in the cellular arrangement all
hepatocytes in a section were taken into account for their counting.
The number of cells under necrosis was highest in group III while
group IV demonstratedthe highest number of cells under apoptosis,
Table 1. Showing the average tail length of comet of the treated cells of different groups.
Name of Group Treatment
Average tail-length
of kidney cells (in mm)
Average tail-length
of liver cells (in mm)
I Saline 7.661.65 6.661.7
II Riboflavin (2 mg/kg) 16.4
**61 13.4
*61.5
III Cisplatin (2 mg/kg) 25.2
**62. 5 21.0
**61.2
IV CP(2 mg/kg)+RF(1 mg/kg) 18.5
##61.2 15.0
#61.5
IV9 CP(2 mg/kg)+RF(1 mg/kg) 23.6
#61.4 19.4
#62
V CP(2 mg/kg)+RF(2 mg/kg) 11.2
##61.5 8.5
##61. 5
V9 CP(2 mg/kg)+RF(2 mg/kg) 21.8
#61.2 17.6
#62
All the data have been expressed in mean 6SEM for six different preparation of each sample of three independent experiments.
*indicates significantly different from control at p#0.05.
**indicates significantly different from control at p#0.01.
#indicates significantly different from group III at p#0.05.
##indicates significantly different from group III at p#0.01.
doi:10.1371/journal.pone.0036273.t001
Figure 2. Showing the average comet picture of liver from
different treated groups of mice. Average comet picture of liver
samples of various treated mice groups divided as (A) Control as Group
I (B) Riboflavin treated as Group II (C) Cisplatin treated as Group III (D)
Combination I as Group IV (E) Combination II as Group V.
doi:10.1371/journal.pone.0036273.g002
Figure 3. Histomicrographs of mice liver of major groups.
Showing histomicrographs of liver samples of various groups indicated
in parentheses. All the sections have been stained with Hematoxylin
and Eosin stain and were snapped at 4006. (A) Control [group I] depicts
normal hepatocellular structure and sinusoids (s). (B) Riboflavin treated
[group II] shows features very akin to normal. (C) Cisplatin treated
[group III] reveals microvesicular changes in the hepatocytes as well as
regions devoid of hepatocytes (*). (D) The combination of cisplatin and
riboflavin treated [group IV] again shows features quite similar to
normal control.
doi:10.1371/journal.pone.0036273.g003
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and 5(B); Figure S1].
FTIR results and analysis
FTIR of combination -II showed that there is a strong
interaction between CP and RF in both the cases. RF showed a
characteristic peak of –NH2 (amide III) group of the alloxazine
ring at 1240.02 cm
21 while CP displayed its characteristic peaks at
and 1558.93 and 1539.24 cm
21 for both of its –NH2 (amide II)
group [17,18]. These peaks demonstrated noticeable shift in case
of their combinations under photoilluminated condition. Hitherto,
the combination without light exposure didn’t show any significant
shift in the peaks. It indicates involvement of the interaction
between the active groups of both the compounds at the molecular
level was pronounced in presence of light.
The combination of CP and RF without photoillumination
showed poor interaction between two compounds as mild alteration
was observed in their characteristic peaks of all the active groups [at
1648.49 and 1630.41 cm
21 (for C=O group) and 1240.02 cm
21
(for –NH group) of alloxazine ring of RF; 1245.85, 1234.96,
1539.24 and 1558.93 cm
21 for two -NH2 groups while 676.81 and
720.12 cm
21 for two chloride groups of CP] (Figures not shown).
Hitherto, the combination generated a series of new peaks (from
1698.71 to 1540.03 cm
21 for –NH groups and 1212.63 and
1188.52 cm
21 for C=O groups) after 1 hour of light exposure
[17,18]. The generation of these novel peaks indicates that an
interaction existed between RF and CP that increased by many
folds after photoillumination [Fig. 6(A) and 6(B)].
Discussion
During prolonged chemotherapy, the clinical usage of CP is
restricted or discontinued because of its severe side effects like ne-
phrotoxicity, hepatotoxicity, neurotoxicity and ototoxicity [2,4,19,20].
Their amelioration has been a great challenge for medical research
since its clinical implementation. The present investigation is aimed to
make CP based chemoradiotherapy more effective and less toxic in
the same league [19,20]. RF is an important ubiquitously occurring
vitamin in all aerobes. Recent studies have demonstrated that RF is a
potential apoptosis inducer in various cancerous strains and have been
recommended as an effective adjuvant therapeutic agent in the
treatment of diverse class of diseases including cancers [21–24].
Our present work for the first time demonstrates that CP-RF
combination is significantly less toxic as demonstrated by comet
assay and histopathology of liver and kidney samples of treated
animals. These results are also supported by our previous study in
which all the major oxidative stress parameters and target organ
functional markers were almost normalized when RF was used
with CP in vivo [7] which is also in agreement with our previous
investigation on mice keratinocytes [16].
Cancer cell lines based studies conducted by various investigators
have demonstrated that riboflavin can activate extrinsic apoptosis
pathway at low concentration in their culture but additional cell
death mechanisms like intrinsic apoptotic pathway and ubiquitin/
proteasome pathway are also triggered at higher concentration of
RF leading to furtherinhibitionin their proliferation[20,21,25]. RF
has also been implicated in downregulation of many anti-apoptotic
factors like P13K, JNK and ERK K phosphorylation as well as
upregulation of many other apoptosis inducing factors like
cytochrome C, Smac/Diablo and htr A2/Omi. Recently, RF has
also been shown to promote extensive vacuole formation in HeLa
and HL-60 cells indicating involvement of autophagy parallel to
intrinsic and extrinsic pathways of apoptosis [26]. Hence, it is
expected that all modes of cell death might get involved when RF
was present in the cancer cell culture. This potential of RF can add
teeth to anticancer drug like CP when used to combat the cancer
cells in vivo as well.
The CPtoxicity intarget organsincludingkidney andliver is very
complex and involves network of various interrelated mechanisms.
CP is supposed to bind with cellular reductants and proteins inside
the cells leading to accumulation of ROS. The invasion of ROS on
the cells causes inflammation locally via upregulation of pro-
inflammatory cytokines (TNF-a, IL-1b and IL-6) as well as
chemokines (CXCL1/KC) that triggers expression of iNOS as well
as the adhesion molecules (e.g., ICAM-1) in the target cells [27]. It
leads to NO generation and adhesion molecules facilitate the
recruitment of inflammatory cells for inflammatory response in the
target cells. Besides, CP mediated inflammation also enhance the
expression of ROS generating phagocytic NADPH oxidases like
NOX4 and NOX2 [28,29]. Hence, oxidative and nitrosative stress
both play roles in CP-mediated toxic insults. Furthermore, these
stresses can activate interrelated downstream pathways such as
the nuclear enzyme PARP that is considered as a hallmark of
irreversible apoptosis induction [30]. As literature suggests that
higher oxidative and nitrosative stress triggers necrosis while its low
to moderate level induces programmed cell death [31], it is possible
in our case that riboflavin is either directly decreasing the stresses by
replenishment of cellular reducing powers and antioxidant enzymes
or maybe it is not allowing CP to cause any organ injury thereby
avoiding any derogatory inflammatory response.
CP also binds to DNA leading to its damage triggering p53
phosphorhylation and activation. After activation, the p53
mediated downstream regulation mechanism can be divided in
two categories: transcription-independent (mitochondrial and
cytosolic) and transcription dependent (nuclear). By transcriptional
regulation, nuclear p53 can activate proapoptotic genes like
PUMA-a, PIDD, caspases and ER-iPLA as well as can also repress
antiapoptotic genes like p21 and taurine transporter (Tau T).
Besides, it is also speculated that p53 may also induce cell death by
Figure 4. Histomicrograph of mice kidney of major groups.
Showing histomicrographs of kidney samples of various groups
indicated in parentheses. All the sections have been stained with
Hematoxylin and Eosin stain and were snapped at 4006. (A) Control
[group I] depicts normal renal corpuscles (Rc) and tubules (T). (B)
Riboflavin treated [group II] shows features very akin to normal. (C)
Cisplatin treated [group III] reveals changes suggestive of dilatation of
tubules, and nuclear cytoplasmic dissociation in the tubular epithelium.
(D) The combination of cisplatin and riboflavin treated [group IV] shows
reasonably intact tubular epithelium and lumen filled with cast (q).
doi:10.1371/journal.pone.0036273.g004
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family proteins in mitochondria or cytosol [32]. Moreover, various
studies entail that increased oxidative and nitrosative stresses can
directly trigger nuclear p53 gene to avoid any DNA damage or
enter apoptosis depending upon the severity of damage and cell
types [31]. However, it is proved that excessive free radicals can
perturb mitochondria and can induce cytochrome C -mediated
apoptosis. In our case, it is possible that RF or CP-RF combination
can favor the apoptosis inducing pathways or it may bring down
the stress level to threshold level which favors apoptosis instead of
necrosis. The results with combination treated mice indicate this
possibility in the present investigation. Furthermore, reduction in
necrotic cell death in group IV organ samples indicates that tissue
damage is minimized with RF supplementation. In addition, the
increase in apoptosis could be index towards the increase in
malignant cell death providing explanation to our preliminary
data on BC-3 cell line in which CP-RF combination has shown
plausible enhancement in cell death under MTT assay (data not
published).
It is documented that low dose of CP triggers apoptosis in the
target cells while necrosis is induced at the higher dose depending
upon the alteration of the redox status of the cells [33,34,35]. RF
and CP individually are known stress inducers in the cells via
generation of various free radical(s) that are able to transcend
organ(s) damage and cause alteration in biomlecules as well as their
respective functions [5,16] but, their interaction in all probabilities
would wane the cellular stress to the level favoring apoptosis as
mode of cell death instead of necrosis [35,36]. This possibly is
operative in our case when CP-RF combination is used leading to
normalization of all the parameterstested[5]. In addition, RF inthe
form of FAD/FMN is used in many energy generating pathways
includingETCand oxidative phosphorylation.IfRFisnotsufficient
in the cancer patients, the aerobic mode of energy generation shifts
to anaerobic glycolysis which is favorable to tumor growth. Hence,
Figure 5. (A): Bar diagram showing average number of cells per renal tubular epithelial cell in kidney section of various groups. All
the data have been expressed in mean 6SEM for five different preparation of each sample. * indicates significantly different from control at p#0.05.
** indicates significantly different from control at p#0.01. # indicates significantly different from group III at p#0.05. ## indicates significantly different
fromgroup III at p#0.01.(B).Bar diagram showing averagenumber ofcells in liver section ofvariousgroups. All the data have been expressed
in mean 6SEMforfivedifferentpreparationofeachsample.*indicatessignificantlydifferentfromcontrolatp#0.05.** indicates significantly different from
control at p#0.01. # indicates significantly different from group III at p#0.05. ## indicates significantly different from group III at p#0.01.
doi:10.1371/journal.pone.0036273.g005
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down thetumerogenesis.RF,inthe presentcontext,inspiteofbeing
proved pro-oxidant, possibly acts as an antioxidant because it has
shown quenching of the free radicals generating potential of CP.
Hence, in the present study, we propose that the quenching is
probably due to molecular interaction between CP and RF via their
excitable groups. Although this interaction happens without
photoillumination but upon exposure of light, RF being a strong
photosensitizer is expected to be excited and hence the process of
enolization is favored leading to formation of stronger co-ordination
between CP and excited RF. This may be the reason for stronger
effect of CP-RF combination under light. Moreover, FTIR analysis
vividly indicates that RF undergoes enolization under photoillumi-
nation. On the other hand, CP undergoes aquation reaction in
water that ultimately forms diammoniumplatinum oxide. The Light
exposure can cleave the p- bond between platinum (Pt) and oxygen
of diammoniumplatinum oxide in heterolytic fashion, making Pt an
electron deficient species (Pt
+). This highly unstable species can
attack at lone pairs of electrons of nitrogen atoms of the alloxazine
ring. Thus, Pt
+ can form four possible complexes through co-
ordination bonding thereby engaging most of CP and RF in
combination. The RF-CP interaction occurs without exposure to
light also because of propensity of RF to interact with CP without
being excited. This could be due to the available lone pair of
electrons on N-atom in the ring of RF which can co-ordinate with
CP easily (Figure 7).
Figure 6. FTIR of CP-RF combination with and without photoillumination. Showing infrared spectra of CP-RF combination in presence and
absence of photoillumination taking wave number (cm
21) and % transmission (%T) at X and Y-axes respectively. (A) FTIR spectra of CP-RF
combination without incubation under light. (B) FTIR spectra of CP-RF combination after I hour of incubation under light.
doi:10.1371/journal.pone.0036273.g006
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alleviation of the drug induced toxicities and improves its
therapeutic potential possibly by assisting in induction of apoptosis
as well as autophagy specifically in the cancer cells and the effect
becomes stronger in light. Furthermore, the literature suggests that
RF can enhance the antineoplastic action of CP and may also
increase the sensitivity in CP resistant cancer cells [20,25,37,38,39].
Hence, supplementation of RF to the cancer patients undergoing
CP based chemotherapy will not only help to overcome the CP
induced side effects but also increase its anticancer activity in all
probabilities. We, therefore suggest with caution prescribing CP-RF
combination followed by low dose of radiation as a better treatment
strategy for cancer patients as compared to CP alone. However, the
anticancer activity of this combination needs to be tested before its
clinical application.
Supporting Information
Figure S1 Statistical analysis of cells of renal tubular
epitheliumand liverhistopathological sectionsatnormal,
apoptotic and necrotic stages. Statistical analysis of cells per
renal tubular epithelium and liver showing normal, apoptotic and
necrotic features was done GraphPad Prism 5.
(DOC)
Table S1 Post hoc analysis of comet tail-length of kidney
and liver samples. Post hoc analysis of comet tail-length of kidney
andliversamplesofvarioustreatmentgroupswasdone byGraphPad
Prism 5. Group I: control Group II: RF Group III: CP Group IV:
Combination I under photoillumination Group IV9: Combination I
without photoillumination Group V: Combination II under photo-
illumination Group V9: Combination II without photoillumination.
(DOC)
Figure 7. Putative mechanism of complex formation between riboflavin and cisplatin. Bio-activated form of cisplatin may eventually
become electron-deficient compound and can interacts with electron-rich alloxazine ring N-atoms of riboflavin (keto-enol forms) in aqueous medium
resulting into formation of four complexes of both the compounds.
doi:10.1371/journal.pone.0036273.g007
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